President Donald Trump’s 25% tariffs on imports from Mexico and Canada took effect Tuesday, and while many industries are about to feel an impact, CEOs say their companies have been working hard to ...

Pfizer (PFE) may move overseas manufacturing to its existing plants in the U.S., if required, as the Trump administration threatens numerous ...

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to its plants in the U.S. as Trump threatens ...

Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...

Pfizer CEO Bourla says company can shift operations from foreign sites to US manufacturing network to counter Trump's tariffs ...

Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...

Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...

Share market today, March 4, 2025: With US President Donald Trump confirming on Monday that tariffs on Mexico and Canada ...

Big Pharma executives feel optimistic about their industry’s trajectory under a second Donald Trump presidency, with regulation rollbacks and other changes likely to boost bottom lines for drugmakers, ...

Albert Bourla, the CEO of Pfizer, stated that the company is prepared to move its overseas manufacturing to the U.S. if ...

CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...